Results 121 to 130 of about 2,380 (175)

Anthelmintic Resistance in Ancylostoma caninum: A Comprehensive Review. [PDF]

Vet Med Sci
Sönmez Hİ, Madak E, Karaer MC, Sarımehmetoğlu HO.   +3 more
europepmc   +1 more source

Repositioning of moxidectin: a promising approach in cutaneous leishmaniasis therapy. [PDF]

Parasite
Al Samra L, El Nahas M, Mneimneh I, Tokajian S, Nemer G, Sinno A, Rahy K, Thoumi S, Zibara Z, El Khatib A, Sabbagh D, Guillot J, Karam L, Ali L, Baghdadi R, Al Khoury C.   +15 more
europepmc   +1 more source

Solvatomorphism of Moxidectin [PDF]

Molecules, 2021
The solvatomorphism of the anthelmintic drug moxidectin is investigated, and a new solvatomorph with nitromethane is reported. Moreover, the hitherto unknown crystal structures of the solvatomorphs with ethanol and 2-propanol are reported and discussed.
Giovanni Battista Giovenzana, Toni Grell, Franco Pattarino   +2 more
exaly   +5 more sources

Moxidectin: an oral treatment for human onchocerciasis [PDF]

Expert Review of Anti-Infective Therapy, 2020
Moxidectin is a milbemycin endectocide recently approved for the treatment of human onchocerciasis. Onchocerciasis, earmarked for elimination of transmission, is a filarial infection endemic in Africa, Yemen, and the Amazonian focus straddling Venezuela and Brazil.
María-Gloria Basáñez, Jonathan Ian Douglas Hamley, Philip Milton   +2 more
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Pharmacokinetics of moxidectin and doramectin in goats

Research in Veterinary Science, 1999
The pharmacokinetic behaviour of doramectin after a single subcutaneous administration and moxidectin following a single subcutaneous or oral drench were studied in goats at a dosage of 0.2 mg kg(-1). The drug plasma concentration-time data were analysed by compartmental pharmacokinetics and non-compartmental methods.
Escudero, E., Carceles, C.M., Diaz, M.S., Sutra, J.F., Galtier, Pierre, Alvinerie, M.   +5 more
openaire   +3 more sources

Decreased ivermectin and moxidectin sensitivity in Haemonchus contortus selected with moxidectin over 14 generations

Veterinary Parasitology, 1999
Ivermectin resistance in the nematode Haemonchus contortus has been reported in many parts of the world and many ivermectin resistant isolates have been found to have reduced sensitivity to moxidectin. However, it is unclear whether parasites that are selected with moxidectin would demonstrate reduced sensitivity to ivermectin.
Roger K Prichard, M B Molento, M B Molento   +2 more
exaly   +3 more sources

Clinical trial of moxidectin oral gel in horses

Veterinary Parasitology, 1997
A clinical trial carried out over 98 days was done to evaluate treatment of horses with moxidectin gel for efficacy as measured by (1) reduction in the production of parasite ova post treatment, (2) a comparison of the posttreatment parasite egg count suppression of moxidectin to ivermectin, and (3) assessment of the field safety, animal acceptance of ...
J A Dipietro
exaly   +3 more sources

A review of the use of moxidectin in horses

Equine Veterinary Education, 2008
Summary Moxidectin has broad‐spectrum anti‐nematodal and anti‐arthropodal activities in the horse but is not effective against tapeworms or flukes. Moxidectin and ivermectin have the same efficacy against internal, adult parasites of horses.

exaly   +2 more sources